Epoetin alfa or darbepoetin alfa for chemo-related anaemia?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1080卷 / 1期
关键词：
Weekly Dose; Darbepoetin Alfa; Retrospective Observational Study; Current Medical Research; Uniform Dose;
D O I：
10.2165/00128415-200510800-00009
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [41] Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure
    Kanbay, Mehmet
    Akcay, Ali
    Delibasi, Tuncay
    Uz, Burak
    Kaya, Arif
    Koca, Cemile
    Turgut, Faruk
    Bavbek, Nuket
    Uz, Ebru
    Duranay, Murat
    Yigitoglu, Ramazan
    ADVANCES IN THERAPY, 2007, 24 (02) : 346 - 352
  • [42] The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa.
    Song, Xue
    Long, Stacey R.
    Marder, William D.
    Sullivan, Sean D.
    Kallich, Joel
    BLOOD, 2008, 112 (11) : 469 - 470
  • [43] Resistance index to epoetin alfa and to darbepoetin alfa in chronic hemodialysis patients:: A cohort study
    Perez-Garcia, R.
    Benitez, P. Rodriguez
    Jofre, R.
    Lopez-Gomez, J. M.
    Villaverde, M. T.
    Blanco, A.
    Blanco, S.
    Sanchez, M.
    NEFROLOGIA, 2007, 27 (03): : 340 - 349
  • [44] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy"
    Nowrousian, Mohammad Resa
    ONCOLOGIST, 2006, 11 (05): : 535 - 536
  • [45] Comparison of anemia treatment outcomes in patients with cancer receiving epoetin alfa and darbepoetin alfa.
    Fahrbach, KR
    Frame, D
    Scheye, R
    Fastenau, JM
    Drielick, M
    Piech, CT
    Nalysnyk, L
    BLOOD, 2003, 102 (11) : 510B - 511B
  • [46] EPOETIN ALFA AND DARBEPOETIN ALFA COSTS BY DOMINANT DOSING INTERVAL IN CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
    Bailey, Robert
    Tunceli, Ozgur
    Singer, Joseph
    Stephenson, Judith
    Senbetta, Mekre
    McKenzie, Scott
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A23 - A23
  • [47] Fluctuations in haemoglobin levels in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa
    Walker, Rowan
    Pussell, Bruce A.
    NEPHROLOGY, 2007, 12 (05) : 448 - 451
  • [48] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CANCER INPATIENTS RECEIVING CHEMOTHERAPY
    Vekeman, F.
    Bailey, R.
    Lafeuille, M. H.
    McKenzie, R. S.
    Herrera, A. D.
    Lefebvre, P.
    VALUE IN HEALTH, 2009, 12 (03) : A40 - A41
  • [49] Epoetin Alfa and Darbepoetin Alfa in Clinical Practice in Patients With Chemotherapy Induced Anemia in the Netherlands (EVALUATE)
    van Groeningen, C. J.
    Kok, T. C.
    Biesma, B.
    Melissant, C. F.
    de Klerk, G.
    Brok, R. G. P. M.
    Lahaye, M.
    Milek, R. L. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S237 - S237
  • [50] Clinical outcomes associated with conversion from epoetin alfa to darbepoetin alfa in hospitalized hemodialysis patients
    Sarac, Erdal
    Chikyarappa, Anand
    Sabol, Brian
    Gemmel, David
    Globe, Denise
    Barlev, Arie
    Audhya, Paul
    AMERICAN JOURNAL OF NEPHROLOGY, 2006, 26 (06) : 571 - 578
12345